Cargando…

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

BACKGROUND: High mobility group box 1(HMGB1) overexpression has been reported in a variety of human cancers. However, the role of HMGB1 in hepatocellular carcinoma (HCC) remains unclear. The aim of present study was to analyze HMGB1 protein expression in tumor, para-tumor and normal tissue and to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Furong, Zhang, Yaojun, Peng, Zhenwei, Gao, Hengjun, Xu, Li, Chen, Minshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441208/ https://www.ncbi.nlm.nih.gov/pubmed/22747650 http://dx.doi.org/10.1186/1479-5876-10-135

Ejemplares similares

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma
por: Zhang, Yaojun, et al.
Publicado: (2017)

High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis
por: Shakya, Manjul, et al.
Publicado: (2018)

Identification of High-Mobility Group Box 1 (HMGB1) Expression as a Potential Predictor of Rejection and Poor Prognosis After Liver Transplantation
por: Ye, Zhou, et al.
Publicado: (2021)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway
por: Cheng, Peng, et al.
Publicado: (2018)

High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005)

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
por: Chen, Qingjie, et al.
Publicado: (2016)

Role of High Mobility Group Box 1 (HMGB1) in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2014)

Developmental expression of high-mobility group box 1 (HMGB1) in the mouse cochlea
por: Liu, Wenjing, et al.
Publicado: (2023)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
por: Dan, Jiaqiang, et al.
Publicado: (2013)

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus
por: Abdulahad, Deena A, et al.
Publicado: (2011)

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
por: Yuan, Shunling, et al.
Publicado: (2020)

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review
por: Ikram, Fathimath Zaha, et al.
Publicado: (2022)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
por: DeWulf, Bram, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma
por: Liu, Furong, et al.
Publicado: (2019)

Family history of hepatocellulcar carcinoma is not associated with its patients’ prognosis after hepatectomy
por: Huang, Jia, et al.
Publicado: (2013)

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
por: Pisetsky, David S, et al.
Publicado: (2008)

High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
por: Ge, Xiaodong, et al.
Publicado: (2014)

The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
por: Sun, Xuqi, et al.
Publicado: (2019)

Correction: The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)

High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression
por: Yasinska, Inna M., et al.
Publicado: (2018)

High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review
por: Qu, Lihua, et al.
Publicado: (2019)

Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
por: Sun, Yan, et al.
Publicado: (2018)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients
por: Handke, Nikolaus A., et al.
Publicado: (2021)

Association of High-Mobility Group Box 1 (HMGB1) Gene Polymorphisms with Susceptibility and Better Survival Prognosis in Chinese Han Neonatal Necrotizing Enterocolitis
por: Cao, Huiling, et al.
Publicado: (2021)

Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma
por: Yang, Zhenyun, et al.
Publicado: (2023)

Propofol Protects Lung Endothelial Barrier Function by Suppression of High-Mobility Group Box 1 (HMGB1) Release and Mitochondrial Oxidative Damage Catalyzed by HMGB1
por: Feng, Zhou, et al.
Publicado: (2019)

High mobility group box 1 (HMGB 1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases
por: PASSALI, D., et al.
Publicado: (2012)

High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis
por: Albayrak, Yavuz, et al.
Publicado: (2011)

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
por: Chung, Hye Won, et al.
Publicado: (2009)

Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
por: Kuroiwa, Yuki, et al.
Publicado: (2013)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?
por: Inkaya, Ahmet Cagkan, et al.
Publicado: (2017)

Evaluation of Graft Effluent High Mobility Group Box-1 (HMGB-1) for Prediction of Outcome After Liver Transplantation
por: Houben, Philipp, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jrj0btukaf8cqkc2gb564irrbe